Oncogenic Tyrosine Kinases Target Dok-1 for Ubiquitin-Mediated Proteasomal Degradation To Promote Cell Transformation

Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue MCB About MCB Subscribers Authors Reviewers Advertisers Inquiries from...

Full description

Saved in:
Bibliographic Details
Published inMolecular and Cellular Biology Vol. 31; no. 13; pp. 2552 - 2565
Main Authors Janas, Justyna A., Van Aelst, Linda
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.07.2011
Taylor & Francis
Subjects
Online AccessGet full text
ISSN0270-7306
1098-5549
1098-5549
DOI10.1128/MCB.05045-11

Cover

Abstract Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue MCB About MCB Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy MCB RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0270-7306 Online ISSN: 1098-5549 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to MCB .asm.org, visit: MCB       
AbstractList Cellular transformation induced by oncogenic tyrosine kinases is a multistep process involving activation of growth-promoting signaling pathways and inactivation of suppressor molecules. Dok-1 is an adaptor protein that acts as a negative regulator of tyrosine kinase-initiated signaling and opposes oncogenic tyrosine kinase-mediated cell transformation. Findings that its loss facilitates transformation induced by oncogenic tyrosine kinases suggest that Dok-1 inactivation could constitute an intermediate step in oncogenesis driven by these oncoproteins. However, whether Dok-1 is subject to regulation by oncogenic tyrosine kinases remained unknown. In this study, we show that oncogenic tyrosine kinases, including p210(bcr-abl) and oncogenic forms of Src, downregulate Dok-1 by targeting it for degradation through the ubiquitin-proteasome pathway. This process is dependent on the tyrosine kinase activity of the oncoproteins and is mediated primarily by lysine-dependent polyubiquitination of Dok-1. Importantly, restoration of Dok-1 levels strongly suppresses transformation of cells expressing oncogenic tyrosine kinases, and this suppression is more pronounced in the context of a Dok-1 mutant that is largely refractory to oncogenic tyrosine kinase-induced degradation. Our findings suggest that proteasome-mediated downregulation of Dok-1 is a key mechanism by which oncogenic tyrosine kinases overcome the inhibitory effect of Dok-1 on cellular transformation and tumor progression.Cellular transformation induced by oncogenic tyrosine kinases is a multistep process involving activation of growth-promoting signaling pathways and inactivation of suppressor molecules. Dok-1 is an adaptor protein that acts as a negative regulator of tyrosine kinase-initiated signaling and opposes oncogenic tyrosine kinase-mediated cell transformation. Findings that its loss facilitates transformation induced by oncogenic tyrosine kinases suggest that Dok-1 inactivation could constitute an intermediate step in oncogenesis driven by these oncoproteins. However, whether Dok-1 is subject to regulation by oncogenic tyrosine kinases remained unknown. In this study, we show that oncogenic tyrosine kinases, including p210(bcr-abl) and oncogenic forms of Src, downregulate Dok-1 by targeting it for degradation through the ubiquitin-proteasome pathway. This process is dependent on the tyrosine kinase activity of the oncoproteins and is mediated primarily by lysine-dependent polyubiquitination of Dok-1. Importantly, restoration of Dok-1 levels strongly suppresses transformation of cells expressing oncogenic tyrosine kinases, and this suppression is more pronounced in the context of a Dok-1 mutant that is largely refractory to oncogenic tyrosine kinase-induced degradation. Our findings suggest that proteasome-mediated downregulation of Dok-1 is a key mechanism by which oncogenic tyrosine kinases overcome the inhibitory effect of Dok-1 on cellular transformation and tumor progression.
Cellular transformation induced by oncogenic tyrosine kinases is a multistep process involving activation of growth-promoting signaling pathways and inactivation of suppressor molecules. Dok-1 is an adaptor protein that acts as a negative regulator of tyrosine kinase-initiated signaling and opposes oncogenic tyrosine kinase-mediated cell transformation. Findings that its loss facilitates transformation induced by oncogenic tyrosine kinases suggest that Dok-1 inactivation could constitute an intermediate step in oncogenesis driven by these oncoproteins. However, whether Dok-1 is subject to regulation by oncogenic tyrosine kinases remained unknown. In this study, we show that oncogenic tyrosine kinases, including p210 bcr-abl and oncogenic forms of Src, downregulate Dok-1 by targeting it for degradation through the ubiquitin-proteasome pathway. This process is dependent on the tyrosine kinase activity of the oncoproteins and is mediated primarily by lysine-dependent polyubiquitination of Dok-1. Importantly, restoration of Dok-1 levels strongly suppresses transformation of cells expressing oncogenic tyrosine kinases, and this suppression is more pronounced in the context of a Dok-1 mutant that is largely refractory to oncogenic tyrosine kinase-induced degradation. Our findings suggest that proteasome-mediated downregulation of Dok-1 is a key mechanism by which oncogenic tyrosine kinases overcome the inhibitory effect of Dok-1 on cellular transformation and tumor progression.
Cellular transformation induced by oncogenic tyrosine kinases is a multistep process involving activation of growth-promoting signaling pathways and inactivation of suppressor molecules. Dok-1 is an adaptor protein that acts as a negative regulator of tyrosine kinase-initiated signaling and opposes oncogenic tyrosine kinase-mediated cell transformation. Findings that its loss facilitates transformation induced by oncogenic tyrosine kinases suggest that Dok-1 inactivation could constitute an intermediate step in oncogenesis driven by these oncoproteins. However, whether Dok-1 is subject to regulation by oncogenic tyrosine kinases remained unknown. In this study, we show that oncogenic tyrosine kinases, including p210bcr-abl and oncogenic forms of Src, downregulate Dok-1 by targeting it for degradation through the ubiquitin-proteasome pathway. This process is dependent on the tyrosine kinase activity of the oncoproteins and is mediated primarily by lysine-dependent polyubiquitination of Dok-1. Importantly, restoration of Dok-1 levels strongly suppresses transformation of cells expressing oncogenic tyrosine kinases, and this suppression is more pronounced in the context of a Dok-1 mutant that is largely refractory to oncogenic tyrosine kinase-induced degradation. Our findings suggest that proteasome-mediated downregulation of Dok-1 is a key mechanism by which oncogenic tyrosine kinases overcome the inhibitory effect of Dok-1 on cellular transformation and tumor progression.
Cellular transformation induced by oncogenic tyrosine kinases is a multistep process involving activation of growth-promoting signaling pathways and inactivation of suppressor molecules. Dok-1 is an adaptor protein that acts as a negative regulator of tyrosine kinase-initiated signaling and opposes oncogenic tyrosine kinase-mediated cell transformation. Findings that its loss facilitates transformation induced by oncogenic tyrosine kinases suggest that Dok-1 inactivation could constitute an intermediate step in oncogenesis driven by these oncoproteins. However, whether Dok-1 is subject to regulation by oncogenic tyrosine kinases remained unknown. In this study, we show that oncogenic tyrosine kinases, including p210(bcr-abl) and oncogenic forms of Src, downregulate Dok-1 by targeting it for degradation through the ubiquitin-proteasome pathway. This process is dependent on the tyrosine kinase activity of the oncoproteins and is mediated primarily by lysine-dependent polyubiquitination of Dok-1. Importantly, restoration of Dok-1 levels strongly suppresses transformation of cells expressing oncogenic tyrosine kinases, and this suppression is more pronounced in the context of a Dok-1 mutant that is largely refractory to oncogenic tyrosine kinase-induced degradation. Our findings suggest that proteasome-mediated downregulation of Dok-1 is a key mechanism by which oncogenic tyrosine kinases overcome the inhibitory effect of Dok-1 on cellular transformation and tumor progression.
Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue MCB About MCB Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy MCB RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0270-7306 Online ISSN: 1098-5549 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to MCB .asm.org, visit: MCB       
Author Justyna A. Janas
Linda Van Aelst
Author_xml – sequence: 1
  givenname: Justyna A.
  surname: Janas
  fullname: Janas, Justyna A.
  organization: Cold Spring Harbor Laboratory, Cold Spring Harbor
– sequence: 2
  givenname: Linda
  surname: Van Aelst
  fullname: Van Aelst, Linda
  email: vanaelst@cshl.edu
  organization: Cold Spring Harbor Laboratory, Cold Spring Harbor
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21536658$$D View this record in MEDLINE/PubMed
BookMark eNp1Uc9PFDEUbgxGFvTm2TRevDDw2m7nx8VEFwUDBA_juWk7ndnqTAttR7L_PWUXjBo99TXfj5f3fQdoz3lnEHpN4JgQWp9crT4eA4clLwh5hhYEmrrgfNnsoQXQCoqKQbmPDmL8DgBlA-wF2qeEs7Lk9QLN1077wTircbsJPlpn8IV1MpqIWxkGk_Cp_1EQ3PuAvyl7O9tkXXFlOiuT6fDX4JOR0U9yxKdmCLKTyXqHW_8ATRnEKzOOuA3SxewxbeGX6Hkvx2hePb6HqP38qV2dF5fXZ19WHy4LvaSQirpqJORRc6g05Uz2ilDoQVPgFVON6jQtFeRDCC2pKhtOFCjW8EY3lWbsEL3f2d7MajKdNi4FOYqbYCcZNsJLK_5EnF2Lwf8UjDDGapIN3j0aBH87m5jEZKPO90hn_BxFXRFWV0vGM_PN76t-7XhKOhPojqBzyjGYXmibtmHkzXYUBMRDnSLXKbZ15m8WHf0levL9D73a0a3bRn3nw9iJJDejD30uQNuYT_u38u1OubbD-s4GI2ScxKRV5gvCBOWcsnseM78q
CitedBy_id crossref_primary_10_18632_oncotarget_2199
crossref_primary_10_1016_j_jare_2021_06_008
crossref_primary_10_1186_s12885_016_2346_6
crossref_primary_10_1016_j_virol_2017_08_018
crossref_primary_10_1371_journal_pone_0107674
crossref_primary_10_1080_2162402X_2019_1649961
crossref_primary_10_1016_j_ebiom_2016_05_003
crossref_primary_10_1371_journal_pone_0087684
crossref_primary_10_1371_journal_pone_0039967
crossref_primary_10_1371_journal_ppat_1004125
crossref_primary_10_4049_jimmunol_1600385
crossref_primary_10_1016_j_bbcan_2015_05_001
crossref_primary_10_1038_cr_2012_47
crossref_primary_10_1038_s42003_024_06771_9
crossref_primary_10_1038_s41375_019_0535_4
Cites_doi 10.1126/science.2408149
10.1128/MCB.20.8.2743-2754.2000
10.1126/science.289.5486.1938
10.1016/S0022-2836(02)01269-X
10.1038/sj.onc.1202171
10.1038/sj.emboj.7600292
10.1038/sj.emboj.7601557
10.1038/onc.2008.242
10.1016/S0092-8674(00)81841-3
10.1111/j.1600-065X.2009.00844.x
10.1073/pnas.97.16.9064
10.1016/j.ccr.2009.05.009
10.1016/0959-437X(94)90086-8
10.1016/S0092-8674(94)90502-9
10.1002/bies.20210
10.1016/S0145-2126(99)00179-4
10.1016/j.biocel.2007.07.012
10.1083/jcb.200312171
10.1074/jbc.M005504200
10.1006/excr.1999.4732
10.1016/j.jmb.2004.08.072
10.1126/science.1127142
10.1128/MCB.19.12.8314
10.1083/jcb.200102032
10.1016/S1074-7613(00)80584-1
10.1016/j.molcel.2007.11.019
10.1038/sj.onc.1203912
10.1101/gad.12.10.1415
10.1093/intimm/dxm015
10.1038/nrm2707
10.1093/emboj/19.19.5114
10.1016/S1074-5521(02)00086-8
10.1074/jbc.M403726200
10.1074/jbc.273.48.32360
10.1073/pnas.0304242101
10.1038/ng.527
10.1016/S0092-8674(00)81840-1
10.1016/S0076-6879(06)06046-0
10.1016/S0968-0004(98)01227-4
10.1016/j.febslet.2009.05.042
10.1016/S0960-9822(99)80458-8
10.1038/343377a0
10.1038/nrc2368
10.1016/S0021-9258(19)78151-4
10.1038/nrc2900
10.1073/pnas.0603948103
10.1126/science.1062538
10.1038/nn1210
10.1038/sj.onc.1202115
10.1074/jbc.273.9.4827
10.1128/MCB.25.9.3831-3841.2005
10.1016/j.ccr.2005.10.015
10.1083/jcb.200707063
10.1038/35077225
10.1074/jbc.M102116200
10.1038/sj.onc.1208796
10.1126/science.1110340
10.1016/j.tcb.2010.01.009
10.1084/jem.194.3.275
10.1084/jem.20041247
10.1016/j.yexcr.2008.07.022
10.1006/meth.2001.1262
10.1084/jem.194.3.265
10.1371/journal.pone.0007728
10.1111/j.1356-9597.2004.00748.x
10.1042/BC20080020
10.1016/j.cellsig.2009.06.002
10.1016/S0092-8674(85)80053-2
10.1128/MCB.26.7.2479-2489.2006
10.1016/j.tcb.2004.01.004
10.1056/NEJMra044389
10.1084/jem.20041306
10.1111/j.1365-2443.2006.00926.x
10.1038/nrc2147
10.1182/blood.V86.6.2371.bloodjournal8662371
10.1093/emboj/18.7.1748
10.1038/sj.onc.1206620
10.1146/annurev.cellbio.22.010605.093503
10.1182/blood.V91.10.3927.3927_3927_3934
10.1016/j.cub.2008.12.007
10.1038/onc.2009.319
10.1126/science.1075762
10.1182/blood-2009-06-228130
10.4049/jimmunol.0901531
10.1093/annonc/mdn048
10.4049/jimmunol.0804172
10.1038/sj.onc.1205317
10.1038/onc.2010.331
10.1016/j.ceb.2009.01.028
10.1006/bbrc.2001.4430
10.1083/jcb.200611063
10.1128/MCB.15.9.4908
ContentType Journal Article
Copyright Copyright © 2011, American Society for Microbiology 2011
Copyright © 2011, American Society for Microbiology 2011 American Society for Microbiology
Copyright_xml – notice: Copyright © 2011, American Society for Microbiology 2011
– notice: Copyright © 2011, American Society for Microbiology 2011 American Society for Microbiology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1128/MCB.05045-11
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1098-5549
EndPage 2565
ExternalDocumentID PMC3133381
21536658
10_1128_MCB_05045_11
12273105
mcb_31_13_2552
Genre Research Article
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: CA-135053
– fundername: NCI NIH HHS
  grantid: R01 CA135053
GroupedDBID ---
-DZ
-~X
0R~
123
18M
29M
2WC
39C
4.4
53G
5RE
5VS
ABTAH
ACGFO
ACNCT
ADBBV
ADIYS
AENEX
AEOZL
AGHSJ
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
H13
HH5
HYE
HZ~
IH2
KQ8
L7B
M4Z
N9A
O9-
OK1
P2P
RHF
RHI
RNS
RPM
RSF
TDBHL
TFL
TFW
TR2
UCJ
UDS
VQA
W8F
WH7
WOQ
ZCA
ZY4
AAGFI
AAYXX
ABJNI
CITATION
TASJS
.55
.GJ
3O-
9M8
ABRLO
ACKIV
ADXHL
AFFNX
C1A
CGR
CUY
CVF
ECM
EIF
EMOBN
MVM
NPM
WHG
X7M
Y6R
YYP
ZGI
ZXP
7X8
5PM
ID FETCH-LOGICAL-c420t-879a0c42c507c253afb120f0c20573b9bdc26b06581262b6951b0b3959c97c33
ISSN 0270-7306
1098-5549
IngestDate Tue Sep 30 15:46:34 EDT 2025
Fri Sep 05 03:49:57 EDT 2025
Mon Jul 21 06:06:39 EDT 2025
Wed Oct 01 02:24:54 EDT 2025
Thu Apr 24 23:08:12 EDT 2025
Wed Dec 25 09:04:52 EST 2024
Wed May 18 15:25:46 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 13
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c420t-879a0c42c507c253afb120f0c20573b9bdc26b06581262b6951b0b3959c97c33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 21536658
PQID 871387435
PQPubID 23479
PageCount 14
ParticipantIDs informaworld_taylorfrancis_310_1128_MCB_05045_11
crossref_citationtrail_10_1128_MCB_05045_11
highwire_asm_mcb_31_13_2552
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3133381
proquest_miscellaneous_871387435
crossref_primary_10_1128_MCB_05045_11
pubmed_primary_21536658
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20110701
7/1/2011
2011-07-01
2011-Jul
PublicationDateYYYYMMDD 2011-07-01
PublicationDate_xml – month: 07
  year: 2011
  text: 20110701
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Molecular and Cellular Biology
PublicationTitleAlternate Mol Cell Biol
PublicationYear 2011
Publisher American Society for Microbiology
Taylor & Francis
Publisher_xml – name: American Society for Microbiology
– name: Taylor & Francis
References Oki S. (B67) 2005; 4
Niki M. (B63) 2004; 200
Janas J. (B38) 2006; 406
Bradshaw R. A. (B10) 1998; 23
Berman E. (B5) 2000; 24
Moran M. F. (B59) 1991; 11
Govek E. E. (B29) 2004; 7
Nelms K. (B61) 1998; 9
Sirvent A. (B79) 2008; 100
Guittard G. (B31) 2009; 182
Titz B. (B84) 2010; 29
McGillicuddy L. T. (B56) 2009; 16
Sabe H. (B73) 1992; 12
Tait S. W. (B83) 2007; 179
Geoffroy M. C. (B26) 2009; 10
Livak K. J. (B50) 2001; 25
Zhao M. (B98) 2006; 26
Lugo T. G. (B51) 1990; 247
Klucher K. M. (B43) 1998; 91
Grimm J. (B30) 2001; 154
Bache K. G. (B2) 2004; 23
Caron C. (B12) 2005; 27
Di Cristofano A. (B21) 2001; 194
Palacios R. (B68) 1985; 41
Wang X. (B89) 2008; 27
Jones N. (B39) 1999; 9
Irby R. B. (B37) 2000; 19
Lee Y. (B48) 2001; 281
Fry W. H. (B24) 2009; 315
Kobayashi R. (B44) 2009; 583
Di Cristofano A. (B20) 1998; 273
Stork B. (B81) 2007; 26
Abram C. L. (B1) 2000; 254
Kirisits A. (B42) 2007; 39
Yasuda T. (B95) 2004; 200
Cadwell K. (B11) 2005; 309
Hosomi Y. (B34) 1994; 269
Ellis C. (B23) 1990; 343
Demers A. (B19) 2009; 4
Bhat A. (B6) 1998; 273
Boettner B. (B8) 2000; 97
Crowder R. J. (B16) 2004; 279
Van Slyke P. (B86) 2005; 25
Treier M. (B85) 1994; 78
Melo J. V. (B57) 2007; 7
Kerscher O. (B41) 2006; 22
Bose R. (B9) 2006; 103
Neviani P. (B62) 2005; 8
Carpino N. (B13) 1997; 88
Wade M. (B87) 2010; 20
Laszlo G. S. (B47) 2009; 19
Yasuda T. (B94) 2007; 19
Cong F. (B15) 1999; 19
Nowicki M. O. (B65) 2003; 22
Barnes D. J. (B3) 2005; 24
Peng C. (B69) 2010; 115
Gaiger A. (B25) 1995; 86
Gorre M. E. (B28) 2001; 293
Zhao M. (B99) 2001; 194
DeClue J. E. (B18) 1993; 13
Krause D. S. (B46) 2005; 353
Manning G. (B52) 2002; 298
Zhang Y. (B97) 2004; 343
Dube N. (B22) 2004; 101
Hunter T (B36) 2009; 21
Schindler T. (B76) 2000; 289
Okada K. (B66) 2006; 312
Polevoda B. (B70) 2003; 325
Suzu S. (B82) 2000; 19
Mashima R. (B54) 2010; 90
Woodring P. J. (B92) 2004; 165
Yamanashi Y. (B93) 1997; 88
Songyang Z. (B80) 2001; 276
Blume-Jensen P. (B7) 2001; 411
Dai Z. (B17) 1998; 12
Kolch W. (B45) 2010; 10
Jones N. (B40) 1998; 17
Wang X. (B88) 2007; 177
Masson K. (B55) 2009; 21
Noguchi T. (B64) 1999; 18
Savona M. (B74) 2008; 8
Porter A. C. (B71) 1998; 17
Shah K. (B77) 2002; 9
Hendrie P. C. (B32) 1991; 19
Mashima R. (B53) 2009; 232
Berger A. H. (B4) 2010; 42
Rodrigues G. A. (B72) 1994; 4
Hunter T (B35) 2007; 28
Yoo Y. (B96) 2010; 29
Scheijen B. (B75) 2002; 21
Lemay S. (B49) 2000; 20
Neet K. (B60) 1995; 15
Ciechanover A. (B14) 2004; 14
Mihrshahi R. (B58) 2009; 183
Shinohara H. (B78) 2004; 9
Wick M. J. (B90) 2001; 276
Honma M. (B33) 2006; 11
Giaccone G. (B27) 2008; 19
Wisniewski D. (B91) 1994; 8
References_xml – volume: 247
  start-page: 1079
  year: 1990
  ident: B51
  publication-title: Science
  doi: 10.1126/science.2408149
– volume: 20
  start-page: 2743
  year: 2000
  ident: B49
  publication-title: Mol. Cell. Biol
  doi: 10.1128/MCB.20.8.2743-2754.2000
– volume: 4
  start-page: 310
  year: 2005
  ident: B67
  publication-title: Cell Cycle
– volume: 289
  start-page: 1938
  year: 2000
  ident: B76
  publication-title: Science
  doi: 10.1126/science.289.5486.1938
– volume: 325
  start-page: 595
  year: 2003
  ident: B70
  publication-title: J. Mol. Biol
  doi: 10.1016/S0022-2836(02)01269-X
– volume: 17
  start-page: 1343
  year: 1998
  ident: B71
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1202171
– volume: 23
  start-page: 2707
  year: 2004
  ident: B2
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7600292
– volume: 26
  start-page: 1140
  year: 2007
  ident: B81
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7601557
– volume: 27
  start-page: 5454
  year: 2008
  ident: B89
  publication-title: Oncogene
  doi: 10.1038/onc.2008.242
– volume: 88
  start-page: 205
  year: 1997
  ident: B93
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81841-3
– volume: 232
  start-page: 273
  year: 2009
  ident: B53
  publication-title: Immunol. Rev
  doi: 10.1111/j.1600-065X.2009.00844.x
– volume: 97
  start-page: 9064
  year: 2000
  ident: B8
  publication-title: Proc. Natl. Acad. Sci. U. S. A
  doi: 10.1073/pnas.97.16.9064
– volume: 16
  start-page: 44
  year: 2009
  ident: B56
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2009.05.009
– volume: 4
  start-page: 15
  year: 1994
  ident: B72
  publication-title: Curr. Opin. Genet. Dev
  doi: 10.1016/0959-437X(94)90086-8
– volume: 78
  start-page: 787
  year: 1994
  ident: B85
  publication-title: Cell
  doi: 10.1016/S0092-8674(94)90502-9
– volume: 27
  start-page: 408
  year: 2005
  ident: B12
  publication-title: Bioessays
  doi: 10.1002/bies.20210
– volume: 11
  start-page: 1804
  year: 1991
  ident: B59
  publication-title: Mol. Cell. Biol
– volume: 24
  start-page: 289
  year: 2000
  ident: B5
  publication-title: Leuk. Res
  doi: 10.1016/S0145-2126(99)00179-4
– volume: 39
  start-page: 2173
  year: 2007
  ident: B42
  publication-title: Int. J. Biochem. Cell Biol
  doi: 10.1016/j.biocel.2007.07.012
– volume: 165
  start-page: 493
  year: 2004
  ident: B92
  publication-title: J. Cell Biol
  doi: 10.1083/jcb.200312171
– volume: 276
  start-page: 2459
  year: 2001
  ident: B80
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.M005504200
– volume: 254
  start-page: 1
  year: 2000
  ident: B1
  publication-title: Exp. Cell Res
  doi: 10.1006/excr.1999.4732
– volume: 343
  start-page: 1147
  year: 2004
  ident: B97
  publication-title: J. Mol. Biol
  doi: 10.1016/j.jmb.2004.08.072
– volume: 312
  start-page: 1802
  year: 2006
  ident: B66
  publication-title: Science
  doi: 10.1126/science.1127142
– volume: 19
  start-page: 8314
  year: 1999
  ident: B15
  publication-title: Mol. Cell. Biol
  doi: 10.1128/MCB.19.12.8314
– volume: 154
  start-page: 345
  year: 2001
  ident: B30
  publication-title: J. Cell Biol
  doi: 10.1083/jcb.200102032
– volume: 9
  start-page: 13
  year: 1998
  ident: B61
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80584-1
– volume: 28
  start-page: 730
  year: 2007
  ident: B35
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2007.11.019
– volume: 12
  start-page: 4706
  year: 1992
  ident: B73
  publication-title: Mol. Cell. Biol
– volume: 19
  start-page: 5636
  year: 2000
  ident: B37
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1203912
– volume: 12
  start-page: 1415
  year: 1998
  ident: B17
  publication-title: Genes Dev
  doi: 10.1101/gad.12.10.1415
– volume: 19
  start-page: 487
  year: 2007
  ident: B94
  publication-title: Int. Immunol
  doi: 10.1093/intimm/dxm015
– volume: 10
  start-page: 564
  year: 2009
  ident: B26
  publication-title: Nat. Rev. Mol. Cell Biol
  doi: 10.1038/nrm2707
– volume: 19
  start-page: 5114
  year: 2000
  ident: B82
  publication-title: EMBO J
  doi: 10.1093/emboj/19.19.5114
– volume: 9
  start-page: 35
  year: 2002
  ident: B77
  publication-title: Chem. Biol
  doi: 10.1016/S1074-5521(02)00086-8
– volume: 279
  start-page: 42072
  year: 2004
  ident: B16
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.M403726200
– volume: 273
  start-page: 32360
  year: 1998
  ident: B6
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.273.48.32360
– volume: 101
  start-page: 1834
  year: 2004
  ident: B22
  publication-title: Proc. Natl. Acad. Sci. U. S. A
  doi: 10.1073/pnas.0304242101
– volume: 42
  start-page: 216
  year: 2010
  ident: B4
  publication-title: Nat. Genet
  doi: 10.1038/ng.527
– volume: 88
  start-page: 197
  year: 1997
  ident: B13
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81840-1
– volume: 406
  start-page: 593
  year: 2006
  ident: B38
  publication-title: Methods Enzymol
  doi: 10.1016/S0076-6879(06)06046-0
– volume: 23
  start-page: 263
  year: 1998
  ident: B10
  publication-title: Trends Biochem. Sci
  doi: 10.1016/S0968-0004(98)01227-4
– volume: 583
  start-page: 2441
  year: 2009
  ident: B44
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2009.05.042
– volume: 9
  start-page: 1057
  year: 1999
  ident: B39
  publication-title: Curr. Biol
  doi: 10.1016/S0960-9822(99)80458-8
– volume: 343
  start-page: 377
  year: 1990
  ident: B23
  publication-title: Nature
  doi: 10.1038/343377a0
– volume: 8
  start-page: 341
  year: 2008
  ident: B74
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2368
– volume: 269
  start-page: 11498
  year: 1994
  ident: B34
  publication-title: J. Biol. Chem
  doi: 10.1016/S0021-9258(19)78151-4
– volume: 10
  start-page: 618
  year: 2010
  ident: B45
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2900
– volume: 103
  start-page: 9773
  year: 2006
  ident: B9
  publication-title: Proc. Natl. Acad. Sci. U. S. A
  doi: 10.1073/pnas.0603948103
– volume: 293
  start-page: 876
  year: 2001
  ident: B28
  publication-title: Science
  doi: 10.1126/science.1062538
– volume: 7
  start-page: 364
  year: 2004
  ident: B29
  publication-title: Nat. Neurosci
  doi: 10.1038/nn1210
– volume: 17
  start-page: 1097
  year: 1998
  ident: B40
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1202115
– volume: 273
  start-page: 4827
  year: 1998
  ident: B20
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.273.9.4827
– volume: 13
  start-page: 6799
  year: 1993
  ident: B18
  publication-title: Mol. Cell. Biol
– volume: 25
  start-page: 3831
  year: 2005
  ident: B86
  publication-title: Mol. Cell. Biol
  doi: 10.1128/MCB.25.9.3831-3841.2005
– volume: 8
  start-page: 355
  year: 2005
  ident: B62
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2005.10.015
– volume: 179
  start-page: 1453
  year: 2007
  ident: B83
  publication-title: J. Cell Biol
  doi: 10.1083/jcb.200707063
– volume: 411
  start-page: 355
  year: 2001
  ident: B7
  publication-title: Nature
  doi: 10.1038/35077225
– volume: 276
  start-page: 42843
  year: 2001
  ident: B90
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.M102116200
– volume: 24
  start-page: 6432
  year: 2005
  ident: B3
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208796
– volume: 309
  start-page: 127
  year: 2005
  ident: B11
  publication-title: Science
  doi: 10.1126/science.1110340
– volume: 20
  start-page: 299
  year: 2010
  ident: B87
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2010.01.009
– volume: 194
  start-page: 275
  year: 2001
  ident: B21
  publication-title: J. Exp. Med
  doi: 10.1084/jem.194.3.275
– volume: 200
  start-page: 1681
  year: 2004
  ident: B95
  publication-title: J. Exp. Med
  doi: 10.1084/jem.20041247
– volume: 315
  start-page: 697
  year: 2009
  ident: B24
  publication-title: Exp. Cell Res
  doi: 10.1016/j.yexcr.2008.07.022
– volume: 25
  start-page: 402
  year: 2001
  ident: B50
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
– volume: 194
  start-page: 265
  year: 2001
  ident: B99
  publication-title: J. Exp. Med
  doi: 10.1084/jem.194.3.265
– volume: 4
  start-page: e7728
  year: 2009
  ident: B19
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0007728
– volume: 9
  start-page: 601
  year: 2004
  ident: B78
  publication-title: Genes Cells
  doi: 10.1111/j.1356-9597.2004.00748.x
– volume: 100
  start-page: 617
  year: 2008
  ident: B79
  publication-title: Biol. Cell
  doi: 10.1042/BC20080020
– volume: 21
  start-page: 1717
  year: 2009
  ident: B55
  publication-title: Cell. Signal
  doi: 10.1016/j.cellsig.2009.06.002
– volume: 41
  start-page: 727
  year: 1985
  ident: B68
  publication-title: Cell
  doi: 10.1016/S0092-8674(85)80053-2
– volume: 26
  start-page: 2479
  year: 2006
  ident: B98
  publication-title: Mol. Cell. Biol
  doi: 10.1128/MCB.26.7.2479-2489.2006
– volume: 14
  start-page: 103
  year: 2004
  ident: B14
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2004.01.004
– volume: 353
  start-page: 172
  year: 2005
  ident: B46
  publication-title: N. Engl. J. Med
  doi: 10.1056/NEJMra044389
– volume: 200
  start-page: 1689
  year: 2004
  ident: B63
  publication-title: J. Exp. Med
  doi: 10.1084/jem.20041306
– volume: 11
  start-page: 143
  year: 2006
  ident: B33
  publication-title: Genes Cells
  doi: 10.1111/j.1365-2443.2006.00926.x
– volume: 90
  start-page: 1357
  year: 2010
  ident: B54
  publication-title: Invest
– volume: 7
  start-page: 441
  year: 2007
  ident: B57
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2147
– volume: 86
  start-page: 2371
  year: 1995
  ident: B25
  publication-title: Blood
  doi: 10.1182/blood.V86.6.2371.bloodjournal8662371
– volume: 18
  start-page: 1748
  year: 1999
  ident: B64
  publication-title: EMBO J
  doi: 10.1093/emboj/18.7.1748
– volume: 22
  start-page: 3952
  year: 2003
  ident: B65
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1206620
– volume: 22
  start-page: 159
  year: 2006
  ident: B41
  publication-title: Annu. Rev. Cell Dev. Biol
  doi: 10.1146/annurev.cellbio.22.010605.093503
– volume: 91
  start-page: 3927
  year: 1998
  ident: B43
  publication-title: Blood
  doi: 10.1182/blood.V91.10.3927.3927_3927_3934
– volume: 19
  start-page: 157
  year: 2009
  ident: B47
  publication-title: Curr. Biol
  doi: 10.1016/j.cub.2008.12.007
– volume: 29
  start-page: 263
  year: 2010
  ident: B96
  publication-title: Oncogene
  doi: 10.1038/onc.2009.319
– volume: 298
  start-page: 1912
  year: 2002
  ident: B52
  publication-title: Science
  doi: 10.1126/science.1075762
– volume: 115
  start-page: 626
  year: 2010
  ident: B69
  publication-title: Blood
  doi: 10.1182/blood-2009-06-228130
– volume: 183
  start-page: 4879
  year: 2009
  ident: B58
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.0901531
– volume: 19
  start-page: 1219
  year: 2008
  ident: B27
  publication-title: Ann. Oncol
  doi: 10.1093/annonc/mdn048
– volume: 8
  start-page: 688
  year: 1994
  ident: B91
  publication-title: Leukemia
– volume: 182
  start-page: 3974
  year: 2009
  ident: B31
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.0804172
– volume: 19
  start-page: 1031
  year: 1991
  ident: B32
  publication-title: Exp. Hematol
– volume: 21
  start-page: 3314
  year: 2002
  ident: B75
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1205317
– volume: 29
  start-page: 5895
  year: 2010
  ident: B84
  publication-title: Oncogene
  doi: 10.1038/onc.2010.331
– volume: 21
  start-page: 140
  year: 2009
  ident: B36
  publication-title: Curr. Opin. Cell Biol
  doi: 10.1016/j.ceb.2009.01.028
– volume: 281
  start-page: 897
  year: 2001
  ident: B48
  publication-title: Biochem. Biophys. Res. Commun
  doi: 10.1006/bbrc.2001.4430
– volume: 177
  start-page: 613
  year: 2007
  ident: B88
  publication-title: J. Cell Biol
  doi: 10.1083/jcb.200611063
– volume: 15
  start-page: 4908
  year: 1995
  ident: B60
  publication-title: Mol. Cell. Biol
  doi: 10.1128/MCB.15.9.4908
SSID ssj0006903
Score 2.1131024
Snippet Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
Cellular transformation induced by oncogenic tyrosine kinases is a multistep process involving activation of growth-promoting signaling pathways and...
SourceID pubmedcentral
proquest
pubmed
crossref
informaworld
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2552
SubjectTerms Cell Line, Tumor
Cell Transformation, Neoplastic - metabolism
DNA-Binding Proteins - metabolism
Down-Regulation
Fusion Proteins, bcr-abl - metabolism
Humans
Lysine - metabolism
Phosphoproteins - metabolism
Proteasome Endopeptidase Complex - metabolism
RNA-Binding Proteins - metabolism
src-Family Kinases - metabolism
Ubiquitin - metabolism
Ubiquitination
Title Oncogenic Tyrosine Kinases Target Dok-1 for Ubiquitin-Mediated Proteasomal Degradation To Promote Cell Transformation
URI http://mcb.asm.org/content/31/13/2552.abstract
https://www.tandfonline.com/doi/abs/10.1128/MCB.05045-11
https://www.ncbi.nlm.nih.gov/pubmed/21536658
https://www.proquest.com/docview/871387435
https://pubmed.ncbi.nlm.nih.gov/PMC3133381
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVFSB
  databaseName: Free Full-Text Journals in Chemistry
  customDbUrl:
  eissn: 1098-5549
  dateEnd: 20250401
  omitProxy: true
  ssIdentifier: ssj0006903
  issn: 0270-7306
  databaseCode: HH5
  dateStart: 19810101
  isFulltext: true
  titleUrlDefault: http://abc-chemistry.org/
  providerName: ABC ChemistRy
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1098-5549
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006903
  issn: 0270-7306
  databaseCode: KQ8
  dateStart: 19890101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1098-5549
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006903
  issn: 0270-7306
  databaseCode: KQ8
  dateStart: 19810101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1098-5549
  dateEnd: 20250401
  omitProxy: true
  ssIdentifier: ssj0006903
  issn: 0270-7306
  databaseCode: DIK
  dateStart: 19810101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1098-5549
  dateEnd: 20250401
  omitProxy: true
  ssIdentifier: ssj0006903
  issn: 0270-7306
  databaseCode: GX1
  dateStart: 19810101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1098-5549
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006903
  issn: 0270-7306
  databaseCode: RPM
  dateStart: 19810101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXQEIKXCcZXGSA_wFOU4tj5fCwVaGIqCClDe7NiJxHRaApL8lB-PdcfSZOuSIyXKE2sKM05vj62fM9F6E1ZlgRokLu5n_iun0jiQgyEjpdFZSYKVhKispFXn8OzC__TZXC5226rs0taMZe_D-aV_A-qcA1wVVmyt0B2eChcgHPAF46AMBz_CeMvtdzAzUo66RZGOyUYz6saxqXGSfUOb9DHV66ntxJeiOpXV7VV7a50dY5CJwkAxM1mrUKfMo0w9ZWcVO3MULv0CmeplvbSkbi1KPY1oPriuiY9DhrrH9bZadidk9U2baxr2m2dOYt5f-sbhJcFDM976wP5bl01Gi9DpDcqgpgBxkRVZVoKuiUZh10b_C292DiIBsbU1g7IIMqCw8GeqgSG1fL9nASgTF0btaf22R4FgeYpl9u7NApDVeTi_OvOUD5MCOvzIWj8bvywqVLp3aP3LG0PTUz299eOBEv6EB3bmQZeGNo8QneK-gTdM7VHtyfo_rIv9fcYdQORcE8kbImEDZGwJhKGN8I3iYRHRMIjIuF0gy2RsCISnhLpCUo_fkiXZ66tx-FKn5IWBs4kI3AqYQ4hacCyUniUlERS5aopEpFLGgqlaT0aUhGCeBdEsCRIZBJJxp6io3pTF88RzpOcCulFoYyknxdBRgVIz6igcZFnMCGfIaf_9Fxar3pVMuUH13NWGnMAimug4OcMvR1a_zQeLX9pd9qjyLNmzddScOZxj3HFuBkiY2B5qxldGjJDu4MPxD34HBBTvSyri03X8DjyWAziPJihZ4YLw5vBH2UhfKMZiiYsGRoow_fpnbr6ro3fmccYKOwXt3_TU_Rg12lfoqP2uitegZpuxWvdH_4Afa7PIQ
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oncogenic+Tyrosine+Kinases+Target+Dok-1+for+Ubiquitin-Mediated+Proteasomal+Degradation+To+Promote+Cell+Transformation&rft.jtitle=Molecular+and+cellular+biology&rft.au=Janas%2C+Justyna+A.&rft.au=Van+Aelst%2C+Linda&rft.date=2011-07-01&rft.pub=Taylor+%26+Francis&rft.eissn=1098-5549&rft.volume=31&rft.issue=13&rft.spage=2552&rft.epage=2565&rft_id=info:doi/10.1128%2FMCB.05045-11&rft.externalDocID=12273105
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-7306&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-7306&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-7306&client=summon